Menu Search
Investment Trusts

Polar Capital Global Healthcare Trust

PCGH:LSE

Polar Capital Global Healthcare Trust

Actions
  • Price (GBX)403.00
  • Today's Change-10.00 / -2.42%
  • Shares traded202.40k
  • 1 Year change+11.63%
  • Beta0.5505
Data delayed at least 20 minutes, as of Mar 03 2026 17:07 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on £1000

1Y
Fund/benchmarkChange
PricePolar Capital Global Healthcare Trust (Ordinary Share)+15.11%
NAVPolar Capital Global Healthcare Trust (Ordinary Share)+8.76%
Morningstar's BenchmarkMSCI ACWI/Health Care NR GBP enhanced--
--
More ▼

Key statistics

On Tuesday, Polar Capital Global Healthcare Trust (PCGH:LSE) closed at 403.00, -8.20% below its 52-week high of 439.00, set on Jan 26, 2026.
52-week range
Today
285.00Apr 07 2025439.00Jan 26 2026
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding98.58m
Market cap407.14m GBP
Total assets402.68m GBP
Total expense ratio--
High415.00
Low398.00
Previous close413.00
Average volume298.22k
YTD Change-4.28%
Beta0.5505
Diluted NAV (est)401.78
Diluted NAV (last pub)408.48
Premium/Discount+0.30%
Net Gearing0.00%
Annual div (ADY)2.20
GBX
Annual div yield (ADY)0.53%
Div ex-dateFeb 05 2026
Div pay-dateFeb 27 2026
Data delayed at least 20 minutes, as of Mar 03 2026 17:07 GMT.
More ▼

Annual Reports

Board of Directors

1/5

Lisa Arnold, Chairman

2/5

Neal Ransome, Director

3/5

Jeremy Whitley, Director

4/5

Caroline Gulliver, Director & Audit Chairman-Elect

5/5

Stacey Parrinder-Johnson, Director

Further Information

Contact

The Company Secretary can be contacted at the Registered Office.

Registered Office:
16 Palace Street
London
SW1E 5JD

T: +44 (0) 20 7227 2700
F: +44 (0) 20 7227 2799
E: investor-relations@polarcapital.co.uk
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.